Karbe Frank insider trades
Karbe Frank has filed 17 Form 4s with the SEC that we hold, for Phathom Pharmaceuticals, Inc. (PHAT) (Director), BTTX (Chief Executive Officer, Director), CDTX (Chief Financial Officer) and MYOV (Principal Fin'l & Accounting). Across all of them we count 4 purchases worth $504.9K and 1 sale worth $70.3K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 242,424 shares of BTTX worth $201.2K, dated 2023-04-10. The first filing on our record is dated 2021-07-09 and the latest 2026-05-21.
Phathom Pharmaceuticals, Inc. (PHAT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-12-13 | P, purchase reported on Form 4 | 12,500 | $99.1K | 2024-12-16 |
BTTX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-09-15 | P, purchase reported on Form 4 | 50,000 | $104.5K | 2022-09-15 |
| 2023-04-10 | P, purchase reported on Form 4 | 242,424 | $201.2K | 2023-04-12 |
| 2023-07-27 | P, purchase reported on Form 4 | 137,005 | $100.0K | 2023-07-31 |
CDTX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MYOV
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-07 | S, sale reported on Form 4 | 3,232 | $70.3K | 2021-07-09 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1276700) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms